trending Market Intelligence /marketintelligence/en/news-insights/trending/hkrm7konlvdnarewrigx5q2 content esgSubNav
In This List

Bal Pharma acquires drug ingredient manufacturer

Blog

Insight Weekly: Ukraine war impact on mining; US bank growth slowdown; cloud computing headwinds

Blog

Insight Weekly: Cryptocurrency's growth; green bond market outlook; coal investors' windfall

Blog

Global M&A By the Numbers: Q1 2022

Blog

Insight Weekly: Challenges for European banks; Japan's IPO slowdown; carmakers' supply woes


Bal Pharma acquires drug ingredient manufacturer

India's Bal Pharma Ltd. fully acquired M/s Golden Drugs Pvt. Ltd., which manufactures active pharmaceutical ingredients and bulk drugs.

The company acquired M/s Golden Drugs' shares at 20.66 Indian rupees each.

Bal Pharma provides pharmaceutical formulations and active pharmaceutical ingredients in India and internationally.

As of March. 22, US$1 was equivalent to 65.15 Indian rupees.